EXHIBIT 10.2
EMPLOYMENT
AGREEMENT
BY AND BETWEEN
JAZZ PHARMACEUTICALS,
INC.
AND
BRUCE C. COZADD
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
Page
|
|
1.
|
|
Integration.
|
|
1
|
|
|
|
|
|
2.
|
|
Definitions.
|
|
2
|
|
|
|
|
|
3.
|
|
Employment.
|
|
8
|
|
|
|
|
|
4.
|
|
Compensation of
the Executive.
|
|
9
|
|
|
|
|
|
5.
|
|
Termination.
|
|
10
|
|
|
|
|
|
6.
|
|
Compensation
Upon Termination.
|
|
11
|
|
|
|
|
|
7.
|
|
Restrictions on
Transfer.
|
|
13
|
|
|
|
|
|
8.
|
|
Repurchase of
Unvested Shares.
|
|
14
|
|
|
|
|
|
9.
|
|
Put/Call Rights
on Vested Shares.
|
|
15
|
|
|
|
|
|
10.
|
|
Permitted
Transfers; Prohibited Transfers.
|
|
16
|
|
|
|
|
|
11.
|
|
Legend; Stop
Transfer Instructions.
|
|
16
|
|
|
|
|
|
12.
|
|
Survival of
Certain Sections.
|
|
17
|
|
|
|
|
|
13.
|
|
Ownership.
|
|
17
|
|
|
|
|
|
14.
|
|
Market
Standoff.
|
|
17
|
|
|
|
|
|
15.
|
|
Escrow of
Shares.
|
|
18
|
|
|
|
|
|
16.
|
|
Assignment and
Binding Effect.
|
|
18
|
|
|
|
|
|
17.
|
|
Notices.
|
|
18
|
|
|
|
|
|
18.
|
|
Governing
Law.
|
|
18
|
|
|
|
|
|
19.
|
|
Amendment and
Waiver.
|
|
18
|
|
|
|
|
|
20.
|
|
Severability.
|
|
19
|
|
|
|
|
|
21.
|
|
Interpretation;
Construction.
|
|
19
|
|
|
|
|
|
22.
|
|
Attorneys’ Fees.
|
|
19
|
|
|
|
|
|
23.
|
|
Cumulative
Remedies.
|
|
19
|
|
|
|
|
|
24.
|
|
Further
Assurances.
|
|
19
|
|
|
|
|
|
25.
|
|
Counterparts.
|
|
20
|
i
EMPLOYMENT
AGREEMENT
This EMPLOYMENT AGREEMENT (the
“ Agreement ”) is made and entered into
on February 18, 2004, by and between JAZZ PHARMACEUTICALS,
INC., a Delaware corporation (the “ Company
”), and BRUCE C. COZADD (the “ Executive
”). The Company and the Executive are hereinafter
collectively referred to as the “ Parties
”, and individually referred to as a “
Party ”.
RECITALS
A. The Company retained the services
of the Executive pursuant to an offer letter, dated April 1,
2003, as amended (the “ Offer Letter
”).
B. In connection with the
Company’s sale of Series A Preferred Stock to investors, the
Executive and the Company entered into the Stock Restriction
Agreement, dated April 30, 2003, as amended (the “
Stock Restriction Agreement ”).
C. The Executive and the Company
entered into the Common Stock Purchase Agreement, dated
October 30, 2003 (the “ Stock Purchase
Agreement ” and, together with the Stock Restriction
Agreement, the “ Stock Agreements
”)
D. Certain parties are now proposing
to purchase shares of the Company’s Series B Preferred Stock
and Series B Prime Preferred Stock.
E. The Company and the Executive
wish to enter into this Agreement in order to (i) amend and
restate the terms and conditions of the Company’s retention
of the Executive’s services and (ii) amend and restate
the terms and conditions of certain restrictions on the capital
stock of the Company held by the Executive.
AGREEMENT
NOW THEREFORE, FOR GOOD AND VALUABLE
CONSIDERATION, THE PARTIES AGREE AS FOLLOWS:
This Agreement and the Transactional
Agreements constitute the entire agreement between the Company and
the Executive regarding the subject matter hereof and thereof and
supersede and replace any and all prior oral and written
negotiations, correspondence, understandings and agreements between
the parties regarding the subject matter hereof and thereof;
provided, however, the Offer Letter, the Stock Agreements, and the
Employee Confidential Information and Inventions Agreement between
the Company and the Executive shall remain in full force and
effect. To the extent this Agreement conflicts with the Offer
Letter or the Stock Agreements, this Agreement controls. To the
extent this Agreement conflicts with the Employee
Confidential
Information and Inventions Agreement, the
Employee Confidential Information and Inventions Agreement
controls. To the extent this Agreement conflicts with the terms of
the Company’s employee handbook in effect from time to time,
this Agreement controls. For purposes of this Agreement, the
“ Transactional Agreements ” shall mean
the Preferred Stock Purchase Agreement (the “ Purchase
Agreement ”) dated January 27, 2004 among the
Company and other parties identified therein, the Amended and
Restated Investor Rights Agreement (the “ Investor
Rights Agreement ”) of even date herewith among the
Company and other parties identified therein, the Amended and
Restated Right of First Refusal and Co-Sale Agreement (the “
Right of First Refusal Agreement ”) of even
date herewith among the Company and the parties identified therein,
and the Amended and Restated Voting Agreement (the “
Voting Agreement ”) of even date herewith among
the Company and the parties identified therein, each as may be
amended in accordance with its terms.
For purposes of this Agreement, the
following terms shall have the following meanings:
2.1. “ Affiliate
” shall mean, with respect to any Person, a Person directly
or indirectly controlling, controlled by, or under common control
with, such Person.
2.2. “ Annual Bonus Rate
for the Termination Year ” shall mean:
2.2.1. if the Executive has not
previously received an annual bonus at the time of termination, the
Executive’s Bonus Rate; and
2.2.2. if the Executive has
previously received an annual bonus payment at the time of
termination, the lesser of the Executive’s Bonus Rate and the
product of the Managers’ Bonus Rate for the year in which the
termination occurs times the Executive’s target bonus
percentage for the year in which the termination occurs.
2.3. “ Annual Bonus Rate
for the Reference Year ” shall mean:
2.3.1. if the Executive has not
previously received an annual bonus at the time of termination, the
Executive’s Bonus Rate; and
2.3.2. if the Executive has
previously received an annual bonus payment at the time of
termination, the lesser of the Executive’s Bonus Rate and the
product of the Managers’ Bonus Rate for the Reference Year
times the Executive’s target bonus percentage for the year in
which the termination occurs.
2.4. “ Call
” shall mean the right of the Company to buy Vested Shares
pursuant to Section 9.4.
2
2.5. “ Cause
” shall mean the occurrence of any of the following
events:
2.5.1. the Executive’s willful
misconduct or gross negligence that is materially injurious to the
Company;
2.5.2. the Executive’s
conviction or plea of guilty or nolo contendere to any felony or
crime involving moral turpitude;
2.5.3. the Executive’s
commission of any act of fraud with respect to the
Company;
2.5.4. the Executive’s willful
violation of any federal or state securities law; or
2.5.5. the Executive’s willful
and continued failure to perform the Executive’s job duties
after 30 days’ written notice from the Board setting forth in
detail the specific respects in which it believes the Executive has
willfully and not substantially performed such job duties and a
failure by Executive to cure within such 30-day period if capable
of being cured.
2.6. “ Change of
Control ” means (i) a sale of all or
substantially all of the assets of the Company to a Person that is
neither an Initial B/P Holder nor an Affiliate of an Initial B/P
Holder, or to a Group that does not include an Initial B/P Holder
or an Affiliate of an Initial B/P Holder, or a sale of all or
substantially all of the assets of the Company to a Person in which
the stockholders of the Company immediately prior to such
transaction do not control more than 50% of the voting power
immediately following the transaction; (ii) a transaction or
series of related transactions by the Company (other than
transaction(s) determined by the Board of Directors to be primarily
for cash financing purposes) or by any stockholder or stockholders
of the Company resulting in more than 50% of the voting power of
the Company being held by a Person that is neither an Initial B/P
Holder nor an Affiliate of an Initial B/P Holder, or by a Group
that does not include an Initial B/P Holder or an Affiliate of an
Initial B/P Holder; (iii) a merger or consolidation of the
Company with or into a Person that is neither an Initial B/P Holder
nor an Affiliate of an Initial B/P Holder, or with or into a Group
that does not include an Initial B/P Holder or an Affiliate of an
Initial B/P Holder, if and only if, after such merger or
consolidation, directors of the Company immediately prior to such
merger or consolidation do not constitute a majority of the
directors of the surviving entity or its parent.
2.7. “ Change of Control
Severance ” shall mean:
2.7.1. an amount, payable in one
lump sum at the time of termination, equal to the product of
(a) one-twelfth of the Executive’s annual base salary in
effect at the time of termination times (b) the number of
months included in the Severance Period, subject to standard
deductions and withholdings;
3
2.7.2. an amount, payable in one
lump sum at the time of termination, equal to the product of the
Executive’s Bonus Rate times the Executive’s base
salary in effect at the time of termination prorated, on the basis
of a 365-day year, to reflect the number of days elapsed in the
year of Executive’s termination prior to and including the
date of termination;
2.7.3. an amount, payable in one
lump sum at the time of termination, equal to the product of
(a) one-twelfth of the Executive’s annual base salary as
in effect at the time of termination times (b) the
Executive’s Bonus Rate times (c) the number of months
included in the Severance Period, subject to standard deductions
and withholdings; and
2.7.4. an amount, payable monthly,
equal to the monthly COBRA payments to continue medical and dental
benefits for a period ending on the earlier of (a) the end of
the last month of the Severance Period and (b) the date on
which the Executive is covered by medical and dental insurance
through his or her own employment.
2.8. “ Common
Shares ” shall mean the shares of Common Stock that
the Executive now owns or hereafter acquires from the
Company.
2.9. “ Complete
Disability ” shall mean the inability of the
Executive to perform the Executive’s duties under this
Agreement because the Executive has become permanently disabled
within the meaning of any policy of disability income insurance
then in force covering employees of the Company. In the event the
Company has no policy of disability income insurance in force
covering employees of the Company, the term “ Complete
Disability ” shall mean the inability of the
Executive to perform the Executive’s duties under this
Agreement by reason of any incapacity, physical or mental, which
the Board, based upon medical advice or an opinion provided by a
licensed physician acceptable to the Board and the Executive,
determines to have incapacitated the Executive from performing all
of the Executive’s usual services for the Company for a
period of at least 120 days during any 12 month period (whether or
not consecutive) and is expected to continue to incapacitate the
Executive thereafter. Based upon such medical advice or opinion,
the determination of the Board shall be final and binding and the
date such determination is made shall be the date of such Complete
Disability for purposes of this Agreement.
2.10. “
Executive’s Bonus Rate ” shall
mean:
2.10.1. if the Executive has not
previously received an annual bonus, the target bonus percentage
for the year in which the termination occurs;
4
2.10.2. if the Executive has
previously received one annual bonus payment at the time of
termination, that percentage calculated by dividing the annual
bonus actually paid for the year to which the bonus relates by the
salary actually paid for such year; or
2.10.3. if the Executive has
received more than one annual bonus payment at the time of
termination, the average over the prior two years of the percentage
calculated by dividing the bonus actually paid for the year to
which the bonus relates by the salary actually paid for such
year.
2.11. “ Fair Market
Value ” shall mean the value of the Shares determined
in good faith by the Board of Directors, provided that
(a)(i) if the Shares are listed on any established stock
exchange or a national market system, their fair market value shall
be the average of the closing sales price for the Shares as quoted
on such system or exchange (or the largest such exchange) over the
5-trading-day period ending immediately prior to the date of the
Notice of Put/Call Exercise, as reported in the Wall Street Journal
or similar publication, and (ii) if the Shares are regularly
quoted by a recognized securities dealer but selling prices are not
reported, their fair market value shall be the mean between the
closing bid and asked prices for the Shares on the date of the
Notice of Put/Call Exercise (or if there are no quoted prices for
such date, then for the last preceding business day on which there
were quoted prices), and (b) if clauses (a)(i) or (a)(ii) are
not applicable, the Board of Directors shall apply valuation
techniques generally used by reputable investment bankers (without
giving effect to any premium that might be paid by a strategic
buyer in an acquisition) to determine the value of the Shares as of
the date of the Notice of Put/Call Exercise.
2.12. “ Founder
Shares ” shall mean shares of Common Stock that the
Executive owns immediately prior to the Initial Closing (as defined
in the Purchase Agreement).
2.13. “ Good
Reason ” shall mean the occurrence of any of the
following events without the Executive’s written
consent:
2.13.1. a substantial diminution by
the Company in the nature or status of the Employee’s
responsibilities or an adverse change in title or reporting level
as they exist on the date of this Agreement, or the addition of
responsibilities of a nature or status inconsistent with the office
of Executive Chairman of a company such as the Company;
2.13.2. the relocation of the
Company’s executive offices or principal business location to
a point more than 20 miles (or greater distance with the prior
written consent of the Executive) from the Company’s current
facilities in Palo Alto, California;
5
2.13.3. a reduction by the Company
of the Executive’s base salary or bonus rate as initially set
forth herein or as the same may be increased from time to time,
other than a comparable across-the-board reduction in base salary
or bonus rate of (a) the Company’s employees generally,
or (b) the senior officers generally (if approved by a
majority of the Company’s senior officers), in each case as a
result of the Company’s need to conserve capital;
2.13.4. any action by the Company
(including the elimination of benefit plans without providing
substitutes thereof or the reduction of the Executive’s
benefits thereunder) that would materially diminish the aggregate
value of the Executive’s fringe benefits as they exist at
such time, other than a comparable across-the-board diminution in
fringe benefits of (a) the Company’s employees
generally, or (b) the senior officers generally (if approved
by a majority of the Company’s senior officers), in each case
as a result of the Company’s need to conserve capital;
or
2.13.5. a material breach of this
Agreement by the Company.
2.14. “ Group
” means two or more Persons acting together as a partnership,
limited partnership, syndicate or other group for the purpose of
acquiring, holding or disposing of or voting securities of the
Company.
2.15. “ Initial B/P
Holder ” means a Person that holds any shares of
Series B/P Preferred as of the date the first share of Series B/P
Preferred is issued.
2.16. “ Manager
” shall mean any of Samuel R. Saks, Bruce C. Cozadd, Robert
M. Myers, Matthew K. Fust, Carol A. Gamble and Janne L. T.
Wissel.
2.17. “ Managers’
Bonus Rate ” shall mean the average for all Managers
of X/Y where X is the actual bonus paid for the year in which a
termination occurs or the Reference Year, as appropriate, and Y is
the target bonus for such year; but including only those Managers
who were employed for the entire year; provided that if there were
no Managers employed for the entire year, then the Managers’
Bonus Rate shall equal the Executive’s Bonus Rate.
2.18. “ Management
Team ” shall mean the Chairman of the Board (if the
Chairman is an officer of the Company), the Chief Executive
Officer, and the management employees reporting directly to the
Chairman or the Chief Executive Officer, in office immediately
prior to a Significant Transaction.
2.19. “ Original
Purchase Price ” for each Share shall mean the price
paid by the Executive for that Share (as appropriately adjusted for
any stock combination, stock split, stock dividend,
recapitalization or other similar transaction after the date
hereof).
6
2.20. “ Person
” means an individual, partnership, corporation, business
trust, joint stock company, trust, unincorporated association,
joint venture, governmental authority or other entity of whatever
nature, and “control” shall have the meaning given such
term under Rule 405 of the Securities Act of 1933, as amended (the
“Securities Act”).
2.21. “ Preferred
Shares ” shall mean the shares of the Company’s
Series A Preferred Stock and Series B Preferred Stock (or Common
Stock issuable upon conversion of the Series A Preferred Stock or
Series B Preferred Stock) that the Executive now owns or hereafter
acquires from the Company.
2.22. “ Put
” shall mean the right of the Executive or his/her estate to
require the Company to buy Vested Shares pursuant to
Section 9.4.
2.23. “ Reference
Year ” shall mean the year following the year in
which the Executive’s employment termination
occurs.
2.24. “ Regular
Severance ” shall mean:
2.24.1. an amount, payable in
accordance with the Company’s customary payroll practices,
for each month during the Severance Period, equal to one-twelfth of
the Executive’s base salary in effect at the time of
termination, subject to standard deductions and withholdings;
plus
2.24.2. an amount, payable monthly,
equal to the monthly COBRA payments to continue medical and dental
benefits for a period ending on the earlier of (a) the end of
the last month of the Severance Period and (b) the date on
which the Executive is covered by medical and dental insurance
through his or her own employment;
2.24.3. an amount, payable at such
time as bonus payments are due to other employees of the Company
for the year in which the termination occurs, equal to the sum of
(a) one-half of the Annual Bonus Rate for the Termination Year
times Executive’s base salary in effect at the time of
termination prorated, on the basis of a 365-day year, to reflect
the number of days elapsed in the year of Executive’s
termination prior to and including the date of termination plus
(b) the Annual Bonus Rate for the Termination Year times
Executive’s base salary in effect at the time of termination
prorated, on the basis of a 365-day year, to reflect the number of
days remaining in the year of Executive’s termination after
the date of termination; and
2.24.4. an amount, payable at such
time as bonus payments are due to other employees of the Company
for the Reference Year, equal to the Annual Bonus Rate for the
Reference Year times the Executive’s base salary in effect at
the time of termination prorated, on the basis of a 365-day year,
to reflect the number of days elapsed in the year of
Executive’s termination prior to and including the date of
termination.
7
2.25. “Right of
Repurchase” shall mean the Company’s right to
repurchase Unvested Shares pursuant to Section 8.1.
2.26. “ Severance
Period ” shall mean 12 months plus one additional
month for each quarter, up to a maximum of 12, that the Executive
has been employed by the Company in excess of two years. For
avoidance of doubt, the maximum Severance Period is two
years.
2.27. “ Shares
” shall mean the Common Shares and the Preferred
Shares.
2.28. “ Significant
Transaction ” shall mean a merger or consolidation of
the Company with or into any Person, or an acquisition of all of
the business of another Person regardless of form, if and only if,
after such merger, consolidation or acquisition, directors of the
Company immediately prior to such merger, consolidation or
acquisition constitute a majority of the directors of the surviving
entity or its parent.
2.29. “ Transactional
Agreements ” shall have the meaning assigned in
Section 1.
2.30. “ Unvested Founder
Shares ” shall mean the Founder Shares held by the
Executive that are then subject to the Right of
Repurchase.
2.31. “ Vested
Shares ” shall mean the Shares held by the Executive
that are not subject to the Right of Repurchase.
2.32. “ Vesting Base
Date ” shall mean the date(s) set forth on Exhibit
A .
3.1. Term . The
Company hereby employs the Executive, and the Executive hereby
accepts employment by the Company, upon the terms and conditions
set forth in this Agreement. The term of the Executive’s
employment under the terms and conditions of this Agreement shall
continue until the fifth anniversary of the date of this Agreement,
subject to the provisions of Section 5.
3.2. Title . The
Executive shall have the title of Executive Chairman of the Company
and shall also serve in such other capacity or capacities as the
Board of Directors of the Company (the “ Board
”) may from time to time prescribe. The Executive shall
report to the Board.
3.3. Duties . The
Executive shall do and perform all services, acts or things
necessary or advisable to manage and conduct the business of the
Company and which are normally associated with the position of
Executive Chairman, consistent with the bylaws of the Company and
as required by the Board.
8
3.4. Location . Unless
the Parties otherwise agree in writing, during the term of
Executive’s employment under this Agreement, the Executive
shall perform the services Executive is required to perform
pursuant to this Agreement at the Company’s offices, located
in Palo Alto, California; provided, however, that the Company may
from time to time require the Executive to travel temporarily to
other locations in connection with the Company’s
business.
3.5. Commitment .
Unless otherwise agreed to in advance by the Company’s Board
of Directors, during the Executive’s employment by the
Company, the Executive shall devote 75% of Executive’s
business energies, interest, abilities and productive time to the
proper and efficient performance of Executive’s duties under
this Agreement; provided, however, the Executive may engage in
other outside business activity listed on Exhibit B hereto.
If the Executive wishes to engage in any other outside work, the
Executive agrees to notify and consult with the Board of Directors
and shall not engage in such other outside work without the prior
approval of the Board of Directors.
|
|
4.
|
Compensation of the
Executive.
|
4.1. Base Salary . The
Company shall pay the Executive a base salary at a rate of
three-hundred seventy-five thousand dollars ($375,000) per year
(based on full-time employment) for calendar year 2004, subject to
increases approved by the Board of Directors for calendar years
thereafter, less payroll deductions and all required withholdings,
payable in regular periodic payments in accordance with Company
policy. Such base salary shall be prorated for any partial year of
employment on the basis of a 365-day year or for part-time
employment.
4.2. Bonus . In
addition to Executive’s base salary, the Executive will be
entitled to receive a bonus determined in accordance with an
executive bonus plan established by the Board of Directors. The
target bonus for the Executive shall be 50% (subject to increases
approved by the Board of Directors) of the annual base salary rate
(pro-rated for part-time employment).
4.3. Employment Taxes
. All of the Executive’s compensation shall be subject to
customary withholding taxes and any other employment taxes as are
commonly required to be collected or withheld by the
Company.
4.4. Benefits . The
Executive shall, in accordance with Company policy and the terms of
the applicable plan documents, be eligible to participate in
benefits under any executive benefit plan or arrangement which may
be in effect from time to time and made available to the
Company’s executive or key management employees.
9
4.5. Vacation .
Executive shall be eligible for paid time off and holidays in
accordance with the Company’s standard policies for executive
employees.
4.6. Expenses . The
Company shall reimburse Executive for all reasonable, documented
out-of-pocket business expenses incurred on behalf of the Company
in the performance of the Executive’s duties.
5.1. Termination by the
Company . The Executive’s employment with the Company
may be terminated under the following conditions:
5.1.1. Death or
Disability . The Executive’s employment with the
Company shall terminate effective upon the date of the
Executive’s death or Complete Disability.
5.1.2. For Cause . The
Company may terminate the Executive’s employment under this
Agreement for Cause by delivery of notice to the Executive
specifying the Cause or Causes relied upon for such termination.
Any notice of termination given pursuant to this Section 5.1.2
shall effect termination as of the future date specified in such
notice or, in the event no such date is specified, on the last day
of the month in which such notice is delivered or deemed delivered
as provided in Section 15 below.
5.1.3. Without Cause .
The Company may terminate the Executive’s employment under
this Agreement at any time for any reason other than for
“Cause” by delivery of notice of such termination to
the Executive. Any notice of termination given pursuant to this
Section 5.1.3 shall effect termination as of the future date
specified in such notice or, in the event no such date is
specified, on the last day of the month in which such notice is
delivered or deemed delivered as provided in Section 15
below.
5.2. Termination By The
Executive . The Executive may terminate the
Executive’s employment with the Company under the following
conditions:
5.2.1. For Good Reason
. The Executive may terminate the Executive’s employment
under this Agreement for Good Reason effective 30 days following
delivery of notice to the Company specifying the Good Reason relied
upon by the Executive for such termination, provid